New combination immunotherapy plus ART expand innate cells critical to controlling HIV
Post-COVID PTSD? Many find return to ‘normal’ unsettling
17 May 2021US nurses working in critical care have been severely impacted by the COVID-19 pandemic
17 May 2021New combination immunotherapy plus ART expand innate cells critical to controlling HIV
Yerkes National Primate Research Center researchers in collaboration with Institut Pasteur have determined a combination immunotherapy of Interleukin-21 (IL-21) and interferon alpha (IFNα) when added to antiviral therapy (ART) is effective in generating highly functional natural killer (NK) cells that can help control and reduce simian immunodeficiency virus (SIV) in animal models. This finding, published online today in Nature Communications, is key for developing additional treatment options to control HIV/AIDS, which impacts 38 million people worldwide.
